Literature DB >> 3353630

Nosocomial bacteremia in a large Spanish teaching hospital: analysis of factors influencing prognosis.

J M Gatell1, A Trilla, X Latorre, M Almela, J Mensa, A Moreno, J M Miro, J A Martinez, M T Jimenez de Anta, E Soriano.   

Abstract

Five hundred forty-three episodes of nosocomial bacteremia were prospectively followed in a large Spanish university hospital. The commonest isolates were Staphylococcus epidermidis, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Candida species. The most frequent sources of infection were intravenous lines, urinary tract, and lower respiratory tract. Overall mortality was 18%. A step-forward logistic regression analysis defined eight variables independently influencing the outcome: shock, underlying rapidly fatal disease, high-risk source of bacteremia (intraabdominal, lower respiratory tract, or not identified), age more than 70 years, hospitalization in intensive care or medical units, inappropriate antibiotic treatment, infection due to a high-risk microorganism (P. aeruginosa, Serratia marcescens, Klebsiella, Bacteroides, or Candida), and development of septic metastasis. The identification of those factors independently influencing the outcome and their possible modification may represent a further step in the control of nosocomial bacteremia by improving its prognosis.

Entities:  

Mesh:

Year:  1988        PMID: 3353630     DOI: 10.1093/clinids/10.1.203

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  14 in total

1.  Rapid differentiation of fermentative from nonfermentative gram-negative bacilli in positive blood cultures by an impedance method.

Authors:  T C Chang; A H Huang
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

2.  Impact of nosocomial polymicrobial bloodstream infections on the outcome in critically ill patients.

Authors:  S Sancho; A Artero; R Zaragoza; J J Camarena; R González; J M Nogueira
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-14       Impact factor: 3.267

Review 3.  Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis.

Authors:  Mical Paul; Vered Shani; Eli Muchtar; Galia Kariv; Eyal Robenshtok; Leonard Leibovici
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

4.  Early and late onset bacteremia have different risk factors in trauma patients.

Authors:  M Antonelli; M L Moro; R R D'Errico; G Conti; M Bufi; A Gasparetto
Journal:  Intensive Care Med       Date:  1996-08       Impact factor: 17.440

5.  Infections in critically ill patients: experience in MICU at a major teaching hospital.

Authors:  N S Dahmash; S C Arora; D F Fayed; M N Chowdhury
Journal:  Infection       Date:  1994 Jul-Aug       Impact factor: 3.553

6.  Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria.

Authors:  Joshua T Thaden; Lawrence P Park; Stacey A Maskarinec; Felicia Ruffin; Vance G Fowler; David van Duin
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

7.  Nosocomial bacteremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes.

Authors:  J Rello; M Ricart; B Mirelis; E Quintana; M Gurgui; A Net; G Prats
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

8.  Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis.

Authors:  M M Huycke; C A Spiegel; M S Gilmore
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

9.  Polymicrobial bacteremia in critically ill patients.

Authors:  J Rello; E Quintana; B Mirelis; M Gurguí; A Net; G Prats
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 10.  Clinical implications of positive blood cultures.

Authors:  C S Bryan
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.